Fsd Pharma Class Stock Price Prediction
| HUGE Stock | USD 0.46 0.03 6.12% |
Oversold Vs Overbought
27
Oversold | Overbought |
FSD Pharma Class stock price prediction is an act of determining the future value of FSD Pharma shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of FSD Pharma's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of FSD Pharma and does not consider all of the tangible or intangible factors available from FSD Pharma's fundamental data. We analyze noise-free headlines and recent hype associated with FSD Pharma Class, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting FSD Pharma's stock price prediction:Wall Street Target Price 6 | Quarterly Revenue Growth (0.07) |
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of FSD Pharma based on different types of headlines from major news networks to social media. The FSD stock price prediction module provides an analysis of price elasticity to changes in media outlook on FSD Pharma over a specific investment horizon. Using FSD Pharma hype-based prediction, you can estimate the value of FSD Pharma Class from the perspective of FSD Pharma response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards FSD Pharma using FSD Pharma's stock options and short interest. It helps to benchmark the overall future attitude of investors towards FSD using crowd psychology based on the activity and movement of FSD Pharma's stock price.
FSD Pharma Implied Volatility | 326.36 |
FSD Pharma's implied volatility exposes the market's sentiment of FSD Pharma Class stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if FSD Pharma's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that FSD Pharma stock will not fluctuate a lot when FSD Pharma's options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in FSD Pharma. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in FSD Pharma to buy its stock at a price that has no basis in reality. In that case, they are not buying FSD because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
FSD Pharma after-hype prediction price | USD 0.46 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
FSD |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of FSD Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
FSD Pharma After-Hype Price Prediction Density Analysis
As far as predicting the price of FSD Pharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in FSD Pharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of FSD Pharma, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
FSD Pharma Estimiated After-Hype Price Volatility
In the context of predicting FSD Pharma's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on FSD Pharma's historical news coverage. FSD Pharma's after-hype downside and upside margins for the prediction period are 0.02 and 4.66, respectively. We have considered FSD Pharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
FSD Pharma is out of control at this time. Analysis and calculation of next after-hype price of FSD Pharma Class is based on 3 months time horizon.
FSD Pharma Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as FSD Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading FSD Pharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with FSD Pharma, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.83 | 4.20 | 0.02 | 0.02 | 3 Events / Month | 2 Events / Month | In about 3 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.46 | 0.46 | 0.00 |
|
FSD Pharma Hype Timeline
FSD Pharma Class is currently traded for 0.46. The entity has historical hype elasticity of -0.02, and average elasticity to hype of competition of 0.02. FSD is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at -0.83%. %. The volatility of related hype on FSD Pharma is about 21000.0%, with the expected price after the next announcement by competition of 0.48. About 17.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.82. Some equities with similar Price to Book (P/B) outperform the market in the long run. FSD Pharma Class recorded a loss per share of 0.46. The entity last dividend was issued on the 16th of October 2019. The firm had 1:201 split on the 16th of October 2019. Given the investment horizon of 90 days the next forecasted press release will be in about 3 days. Check out FSD Pharma Basic Forecasting Models to cross-verify your projections.FSD Pharma Related Hype Analysis
Having access to credible news sources related to FSD Pharma's direct competition is more important than ever and may enhance your ability to predict FSD Pharma's future price movements. Getting to know how FSD Pharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how FSD Pharma may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| BHHKF | Benchmark Botanics | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SPBBF | Speakeasy Cannabis Club | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CVGRF | City View Green | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| RVVQF | Ravenquest Biomed | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SXTC | China SXT Pharmaceuticals | 0.03 | 5 per month | 0.00 | (0.05) | 10.45 | (12.61) | 65.62 | |
| BFRI | Biofrontera | 0.15 | 6 per month | 10.17 | 0.04 | 24.68 | (18.71) | 74.86 | |
| LSDI | Lucy Scientific Discovery | 0.02 | 5 per month | 0.00 | (0.13) | 13.21 | (11.11) | 35.52 | |
| LRSV | Link Reservations | 0.00 | 0 per month | 15.80 | 0.13 | 100.00 | (50.00) | 150.00 | |
| MKGAF | MERCK Kommanditgesellschaft auf | 0.00 | 0 per month | 2.01 | (0.04) | 3.45 | (3.22) | 9.28 | |
| GCAN | Greater Cannabis | 0.00 | 0 per month | 10.58 | 0.06 | 25.00 | (20.00) | 66.67 |
FSD Pharma Additional Predictive Modules
Most predictive techniques to examine FSD price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for FSD using various technical indicators. When you analyze FSD charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About FSD Pharma Predictive Indicators
The successful prediction of FSD Pharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as FSD Pharma Class, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of FSD Pharma based on analysis of FSD Pharma hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to FSD Pharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to FSD Pharma's related companies. | 2022 | 2023 | 2024 (projected) | Payables Turnover | 1.58 | 0.79 | 0.86 | Days Of Inventory On Hand | 0.018 | 2.86E-4 | 2.72E-4 |
Story Coverage note for FSD Pharma
The number of cover stories for FSD Pharma depends on current market conditions and FSD Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that FSD Pharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about FSD Pharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
FSD Pharma Short Properties
FSD Pharma's future price predictability will typically decrease when FSD Pharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of FSD Pharma Class often depends not only on the future outlook of the potential FSD Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. FSD Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 39.6 M | |
| Cash And Short Term Investments | 3.5 M |
Check out FSD Pharma Basic Forecasting Models to cross-verify your projections. Note that the FSD Pharma Class information on this page should be used as a complementary analysis to other FSD Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Complementary Tools for FSD Stock analysis
When running FSD Pharma's price analysis, check to measure FSD Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy FSD Pharma is operating at the current time. Most of FSD Pharma's value examination focuses on studying past and present price action to predict the probability of FSD Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move FSD Pharma's price. Additionally, you may evaluate how the addition of FSD Pharma to your portfolios can decrease your overall portfolio volatility.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is FSD Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of FSD Pharma. If investors know FSD will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about FSD Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.46) | Quarterly Revenue Growth (0.07) | Return On Assets (0.43) | Return On Equity (0.84) |
The market value of FSD Pharma Class is measured differently than its book value, which is the value of FSD that is recorded on the company's balance sheet. Investors also form their own opinion of FSD Pharma's value that differs from its market value or its book value, called intrinsic value, which is FSD Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because FSD Pharma's market value can be influenced by many factors that don't directly affect FSD Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between FSD Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if FSD Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, FSD Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.